Prospective Double-blind Study for the Use of Aspirin During Transurethral Surgery of the Bladder or the Prostate

NCT ID: NCT00861367

Last Updated: 2024-03-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

WITHDRAWN

Clinical Phase

NA

Study Classification

INTERVENTIONAL

Study Start Date

2008-09-30

Study Completion Date

2009-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Aspirin is very common in older patients. Therefore many of the investigators patients have aspirin. The aim of the study is to proof that Transurethral Surgery of the bladder or the prostate can be performed with aspirin.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Blood Loss, Surgical Intraoperative Complications Re-operation Rates in Patients With Aspirin Treatment

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Caregivers Investigators

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

aspirin 100mg

Group Type ACTIVE_COMPARATOR

transurethral surgery with or without aspirin

Intervention Type DRUG

aspirin 100mg once a day, transurethral surgery with or without aspirin

2

empty capsule

Group Type PLACEBO_COMPARATOR

transurethral surgery with or without aspirin

Intervention Type DRUG

aspirin 100mg once a day, transurethral surgery with or without aspirin

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

transurethral surgery with or without aspirin

aspirin 100mg once a day, transurethral surgery with or without aspirin

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Asprin cardio 100mg

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Transurethral surgery of the bladder or prostate, informed consent, age over 18

Exclusion Criteria

* Oral anticoagulation,
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Basel, Switzerland

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thomas C Gasser, Prof

Role: STUDY_CHAIR

Department of Urology, Liestal

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Urologische Universitätsklinik Basel-Liestal

Liestal, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

05/08

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.